To the full analysis
Buyback calculator for Prestige Consumer Healthcare
Prestige Consumer Healthcare stock: key metrics
PBHPrestige Consumer Healthcare had an operating margin of 28.4% and a return on invested capital (ROIC) of 8.1% in fiscal 2026.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2007 | 51.9% | 29.7% | 11.3% |
| 2008 | 51.6% | 28.0% | 10.4% |
| 2009 | 52.2% | −53.6% | −59.7% |
| 2010 | 52.1% | 26.1% | 10.6% |
| 2011 | 50.8% | 22.6% | 8.7% |
| 2012 | 51.6% | 23.3% | 8.4% |
| 2013 | 55.7% | 30.8% | 10.5% |
| 2014 | 56.5% | 31.3% | 12.1% |
| 2015 | 56.8% | 29.0% | 11.0% |
| 2016 | 57.9% | 32.3% | 12.4% |
| 2017 | 56.7% | 23.3% | 7.9% |
| 2018 | 55.4% | 20.7% | 32.6% |
| 2019 | 56.9% | 6.9% | −3.7% |
| 2020 | 57.3% | 30.2% | 14.8% |
| 2021 | 58.0% | 31.5% | 17.5% |
| 2022 | 57.1% | 30.4% | 18.9% |
| 2023 | 55.4% | −2.0% | −7.3% |
| 2024 | 55.5% | 30.4% | 18.6% |
| 2025 | 55.8% | 29.6% | 18.9% |
| 2026 | 52.8% | 28.4% | 17.5% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2007 | 8.1% | 6.9% | 3.4% |
| 2008 | 7.1% | 6.4% | 3.2% |
| 2009 | −63.4% | −17.4% | −23.3% |
| 2010 | 9.8% | 7.4% | 4.1% |
| 2011 | 8.1% | 6.3% | 2.8% |
| 2012 | 9.2% | 5.3% | 2.1% |
| 2013 | 13.7% | 8.1% | 3.8% |
| 2014 | 12.9% | 9.3% | 4.0% |
| 2015 | 12.5% | 7.0% | 2.9% |
| 2016 | 13.4% | 7.3% | 3.4% |
| 2017 | 8.4% | 4.8% | 1.8% |
| 2018 | 28.8% | 7.1% | 9.0% |
| 2019 | −3.3% | 1.8% | −1.0% |
| 2020 | 12.2% | 7.6% | 4.0% |
| 2021 | 12.1% | 8.4% | 4.8% |
| 2022 | 13.0% | 8.8% | 5.6% |
| 2023 | −5.7% | −0.6% | −2.5% |
| 2024 | 12.6% | 9.4% | 6.3% |
| 2025 | 11.7% | 9.2% | 6.3% |
| 2026 | 10.1% | 8.1% | 5.4% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 14 Mar 2025)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.